4.2
1045 reviewsAt the heart of Blue Guardian Capital Prop Firm lies a commitment to empowering traders, enabling them to leverage substantial accounts for optimal profit sharing.
Open account About Challenges Discount Codes ReviewsBlue Guardian, established in June 2019 and becoming public in September 2021, extends to traders the chance to achieve substantial profit shares through trading with significant leveraged accounts. Traders now have the capability to manage capital balances up to $1,800,000.
Blue Guardian evaluation program is designed to spotlight and nurture traders of high caliber who demonstrate consistent performance over a structured two-phase assessment period. This program grants traders the opportunity to engage in trading activities with a leverage of 1:100.
In the initial phase, participants are tasked with achieving a profit goal of 6%, while staying within the parameters of a 4% maximum daily loss and a 10% overall loss limit, all within a 30-day timeframe from the commencement of trading on the evaluation account. A minimum trading duration of 5 days is required to advance to the subsequent phase.
The second phase mirrors the first in terms of objectives and constraints: participants must again secure a 6% profit, adhering to the same loss limitations, but this time over a 60-day period from the initiation of trading activities.
Successful completion of both phases rewards traders with a funded account devoid of profit targets, subject to the continued observance of the 4% maximum daily loss and 10% total loss restrictions. Profit distributions from the funded account commence 14 days following the initial trade, with traders entitled to up to an 85% share of the profits earned.
CEO
$25,000, $50,000, $100,000, $200,000
Purple Trading
MT4
2019
😕 Sorry, we don't have any challenges from Blue Guardian in the database yet. We're working on it!
😕 Sorry, we don't have any discount & promo codes for Blue Guardian right now. Check it out later!
Subscribe and start making the most of every engagement.